AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive OfficerPRNewsWire • 02/22/24
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control SolutionPRNewsWire • 02/21/24
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-InsecticidePRNewsWire • 02/20/24
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic InnovationPRNewsWire • 02/06/24
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement SummitPRNewsWire • 01/23/24
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology DrugPRNewsWire • 01/17/24
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024PRNewsWire • 12/21/23
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™PRNewsWire • 12/05/23
Bears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' NowZacks Investment Research • 11/29/23
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and BarleyPRNewsWire • 11/28/23
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial ResultsPRNewsWire • 11/08/23
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023PRNewsWire • 11/02/23
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing TechnologyPRNewsWire • 10/31/23
Evogene (EVGN) Could Find a Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 08/21/23
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff CenterPRNewsWire • 08/15/23
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023PRNewsWire • 08/01/23